FBXW7 and colorectal carcinoma: FBXW7 loss in CRC associates with CD8+ T-cell exhaustion, UPR activation, WNT/β-catenin dependency, and heightened sensitivity to PPAR inhibition, revealing potential therapeutic vulnerabilities.